Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

PLoS ONE

Volumn 2, Issue 8, 2007, Pages

  Bejon, Philip ^a   Ogada, Edna ^a   Mwangi, Tabitha ^a,b   Milligan, Paul ^c   Lang, Trudie ^b   Fegan, Greg ^a,c   Gilbert, Sarah C ^d   Peshu, Norbert ^a   Marsh, Kevin ^a,e   Hill, Adrian V S ^b,d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; LIVE ATTENUATED FOWLPOX VIRUS PLUS MODIFIED VACCINIA VIRUS ANKARA PLUS MULTIPLE EPITOPE STRING AND THROMBOSPONDIN RELATED ADHESION PROTEIN VACCINE; MALARIA VACCINE; RABIES VACCINE; UNCLASSIFIED DRUG;

ARTICLE; AXILLA TEMPERATURE; BLOOD SMEAR; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DYSENTERY; FEVER; FOLLOW UP; GASTROENTERITIS; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA; OUTCOME ASSESSMENT; PARASITE EXAMINATION; PARASITEMIA; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STEVENS JOHNSON SYNDROME; TEMPERATURE MEASUREMENT; TREATMENT DURATION;

ADULT; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; KENYA; MALARIA; MALARIA VACCINES; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS;

POXVIRIDAE; VACCINIA VIRUS ANKARA;

EID: 40349087409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000707     Document Type: Article

References (7)